Studies on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of the molecule and its serum half-life and in vivo biological activity, but an
Joan C. Egrie, PhD
Advertisement
Articles by Joan C. Egrie, PhD
Advertisement
Latest Updated Articles
- Development and Characterization of Darbepoetin Alfa
Published: October 1st 2002 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
What Were The Most Impactful GU Oncology Data From ESMO 2025?
4
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
5
